317 related articles for article (PubMed ID: 32519930)
1. Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.
Chen X; Wu M; Xu K; Huang M; Zhuo X
Acta Cardiol; 2021 Feb; 76(1):87-92. PubMed ID: 32519930
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate antigen 125 combined with N-terminal pro-B-type natriuretic peptide in the prediction of acute heart failure following ST-elevation myocardial infarction.
Xu K; Wu M; Huang M; Zhuo X; Weng Y; Chen X
Medicine (Baltimore); 2022 Dec; 101(48):e32129. PubMed ID: 36482545
[TBL] [Abstract][Full Text] [Related]
3. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
4. CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.
Soler M; Miñana G; Santas E; Núñez E; de la Espriella R; Valero E; Bodí V; Chorro FJ; Fernández-Cisnal A; D'Ascoli G; Marti-Cervera J; Sanchis J; Bayes-Genís A; Núñez J
Int J Cardiol; 2020 Jun; 308():54-59. PubMed ID: 32209267
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
[TBL] [Abstract][Full Text] [Related]
6. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
7. CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure.
Núñez-Marín G; de la Espriella R; Santas E; Lorenzo M; Miñana G; Núñez E; Bodí V; González M; Górriz JL; Bonanad C; Sanchis J; Bayés-Genís A; Núñez J
Eur Heart J Acute Cardiovasc Care; 2021 Jun; 10(5):475-483. PubMed ID: 33829233
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure.
de la Espriella R; Bayés-Genís A; Llàcer P; Palau P; Miñana G; Santas E; Pellicer M; González M; Górriz JL; Bodi V; Sanchis J; Núñez J
Eur J Intern Med; 2022 Jan; 95():67-73. PubMed ID: 34507853
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure.
Yoon JY; Yang DH; Cho HJ; Kim NK; Kim CY; Son J; Roh JH; Jang SY; Bae MH; Lee JH; Park HS; Cho Y; Chae SC
Korean J Intern Med; 2019 Jul; 34(4):811-818. PubMed ID: 30616330
[TBL] [Abstract][Full Text] [Related]
10. Old markers, new approach to assessment of risk in heart failure.
Kodziszewska K; Leszek P; Korewicki J; Piotrowski W
Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the N-terminal pro-brain natriuretic peptide and B-type natriuretic peptide ratio in the acute phase of acute heart failure.
Sawatani T; Shirakabe A; Okazaki H; Matsushita M; Shibata Y; Shigihara S; Otsuka Y; Kiuchi K; Kobayashi N; Hata N; Shimizu W; Asai K
Eur Heart J Acute Cardiovasc Care; 2021 Dec; 10(9):1016-1026. PubMed ID: 34432003
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
[TBL] [Abstract][Full Text] [Related]
13. Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure.
Llàcer P; Gallardo MÁ; Palau P; Moreno MC; Castillo C; Fernández C; de la Espriella R; Mollar A; Santas E; Miñana G; Manzano L; Bayés-Genís A; Núñez J
Med Clin (Barc); 2021 Jun; 156(12):589-594. PubMed ID: 32951882
[TBL] [Abstract][Full Text] [Related]
14. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.
Chuang CP; Jong YS; Wu CY; Lo HM
Am J Cardiol; 2014 Mar; 113(5):845-50. PubMed ID: 24406111
[TBL] [Abstract][Full Text] [Related]
15. Comparison of prognostic value of red cell distribution width and NT-proBNP for short-term clinical outcomes in acute heart failure patients.
He W; Jia J; Chen J; Qin S; Tao H; Kong Q; Xue Q; Zhang D
Int Heart J; 2014; 55(1):58-64. PubMed ID: 24463920
[TBL] [Abstract][Full Text] [Related]
16. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
17. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.
Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M
BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112
[TBL] [Abstract][Full Text] [Related]
18. The potential role of NT-proBNP in screening for and predicting prognosis in heart failure: a survival analysis.
Taylor CJ; Roalfe AK; Iles R; Hobbs FD
BMJ Open; 2014 Apr; 4(4):e004675. PubMed ID: 24747793
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
20. Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure.
Aimo A; Januzzi JL; Mueller C; Mirò O; Pascual Figal DA; Jacob J; Herrero-Puente P; Llorens P; Wussler D; Kozhuharov N; Sabti Z; Breidthardt T; Vergaro G; Ripoli A; Prontera C; Saccaro L; Passino C; Emdin M
Int J Cardiol; 2019 Oct; 293():137-142. PubMed ID: 31200964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
